Furo[2,3-d]pyrimidin-2(3H)-one, 3-(2-deoxy-β-D-erythro-pentofuranosyl)-6-(4-pentylphenyl)- structure
|
Common Name | Furo[2,3-d]pyrimidin-2(3H)-one, 3-(2-deoxy-β-D-erythro-pentofuranosyl)-6-(4-pentylphenyl)- | ||
|---|---|---|---|---|
| CAS Number | 319425-66-6 | Molecular Weight | 398.45200 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H26N2O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Furo[2,3-d]pyrimidin-2(3H)-one, 3-(2-deoxy-β-D-erythro-pentofuranosyl)-6-(4-pentylphenyl)-CF-1743 is an anti-varicella zoster virus nucleoside and inhibits VZV replication. CF-1743 can be used in studies about infection of varicella and herpes zoster. |
| Name | 3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-2-one |
|---|---|
| Synonym | More Synonyms |
| Description | CF-1743 is an anti-varicella zoster virus nucleoside and inhibits VZV replication. CF-1743 can be used in studies about infection of varicella and herpes zoster. |
|---|---|
| References | 1. De Clercq E. Highly potent and selective inhibition of varicella-zoster virus replication by bicyclic furo[2,3-d]pyrimidine nucleoside analogues. Med Res Rev. 2003 May;23(3):253-74. |
| Molecular Formula | C22H26N2O5 |
|---|---|
| Molecular Weight | 398.45200 |
| Exact Mass | 398.18400 |
| PSA | 97.72000 |
| LogP | 3.02990 |
| Cf1743 |
| UNII-5XGI48Q2DH |
| 6-(4-Pentyl-phenyl)-3-((2R,4S,5R)-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3H-furo[2,3-d]pyrimidin-2-one |